
Avoiding Measles During Pregnancy: A Fetal Specialist Offers Clinical Considerations
After the CDC declined to issue a health alert on measles in pregnancy, Karen Koscica, DO, FACOG, explains where clinicians can find guidance, the maternal and fetal risks of infection, and why women considering pregnancy should have their measles titers checked.
In September, scientists at the CDC sought to warn clinicians nationwide about the rising risks of measles during pregnancy through the agency’s Health Alert Network, but the alert was not approved, according to The Washington Post.¹ The alert, which typically requires sign-off from the CDC director’s office, would have provided guidance for care as US cases reached 4,852 for 2026. An HHS spokesperson did not address why the alert was declined, telling the Post the report was moving through scientific review and clearance.¹
The data instead appeared November 16 as a preliminary analysis in NEJM Evidence, published in partnership with the Center for Infectious Disease Research and Policy.² From January 1, 2025, through September 28, 2026, the CDC received reports of 112 confirmed measles cases during pregnancy and 13 cases of congenital measles. Of the pregnant patients, 98% (110/112) were unvaccinated or had unknown vaccination status, and none had documented immune globulin as postexposure prophylaxis.²
Maternal complications included hospitalization for reasons unrelated to labor in 23% (26/112) and pneumonia in 10% (11/112).² Among 19 infants born within 14 days of maternal rash onset, 42% (8/19) were preterm and 42% (8/19) required NICU admission. Congenital measles was confirmed in 81% (13/16) of infants tested.²
One day after publication, the Pan American Health Organization formally withdrew the US measles elimination status held since 2000.³ With sustained transmission and no federal alert to clinicians, responsibility for preconception screening, exposure management, and counseling now rests largely with individual practices and specialty societies.
Karen Koscica, DO, FACOG, a maternal fetal medicine specialist, obstetrician-gynecologist, and division director of maternal fetal medicine at Hackensack Meridian Jersey Shore University Medical Center, offers a frontline obstetric perspective on these risks. In the following interview, Koscica discusses where clinicians can turn for guidance, the maternal and fetal consequences of measles infection, and the role of preconception titer testing.
Contagion: What does losing measles elimination status mean for US public health?
Koscica: Losing the measles elimination status here in the US means that high-risk populations that cannot be vaccinated, such as pregnant women with no immunity or young babies, are at high risk for complications from the infection.
Contagion: With reports the CDC declined to issue a congenital measles alert, where should clinicians turn for treatment guidance?
Koscica: Clinicians can look at medical society recommendations, such as those from ACOG or SMFM, for information on measles, especially in pregnancy. Medical personnel can also reach out to their institutional infectious disease clinic for guidance.
Contagion: What should clinicians know about congenital measles, and why should expectant mothers be aware of it?
Koscica: Pregnant patients who are at risk for developing measles can have severe complications during pregnancy. They are especially at risk for pneumonia, which could lead to hospital admission and even death. Unborn babies are at risk for prematurity, low birth weight, NICU admission, respiratory illness, and, in severe cases, encephalitis.
Contagion: Should measles titers be checked in all expectant mothers, and should revaccination be considered amid widespread outbreaks?
Koscica: All women who are considering becoming pregnant should have titers checked. If they are not immune, they should be given the vaccine. The MMR vaccine is considered a live vaccine and is contraindicated in pregnancy. But if a patient has received the vaccine and is unknowingly pregnant, there have been no documented cases of congenital measles from the vaccine.
Editor’s Note: This transcript has been edited for grammar and clarity using artificial intelligence tools.
References
Sun LH. CDC scientists sought urgent alert on measles in pregnancy. It wasn’t approved. The Washington Post. Published October 30, 2026. Accessed November 20, 2026.
https://www.washingtonpost.com/health/2026/10/30/cdc-has-report-measles-pregnancy-its-unclear-when-it-will-publish/ Lewis EL, Chang D, Wiley N, et al. Outcomes among pregnant women with measles and their infants in the United States — preliminary analysis, 2025–2026. NEJM Evid. Published online November 16, 2026. doi:10.1056/EVIDpha2600416
Benadjaoud Y. US officially loses measles elimination status, PAHO says. ABC News. Published November 17, 2026. Accessed November 20, 2026.
https://abc7ny.com/story/us-officially-loses-measles-elimination-status-paho-says/20048136/
Related to this article








